| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Ghrelin Research Group, School of Life Sciences, Queensland University of Technology, Brisbane 4001, Australia
Address all correspondence and requests for reprints to: Penny Jeffery, School of Life Sciences, Queensland University of Technology, GPO Box 2434, Brisbane 4001, Australia. E-mail: p.jeffery{at}student.qut.edu.au.
Ghrelin, an n-octanoylated 28-amino-acid peptide capable of inducing GH secretion and food intake in humans and rats, is the endogenous ligand for the GH secretagogue receptor (GHS-R). Here we describe the expression and tissue distribution of the ghrelin/GHS-R axis in the mouse. We also report for the first time the identification of a novel mouse ghrelin mRNA variant in which there is a complete deletion of exon 4. Translation of this variant mRNA yields a protein containing ghrelin and an alternative C-terminal domain with a unique C-terminal peptide sequence. RT-PCR with primers specific for mouse ghrelin was used to demonstrate the mRNA expression of the full preproghrelin transcript and the exon 4-deleted variant in multiple mouse tissues. Real-time PCR was also employed to quantitate mRNA expression of ghrelin, the novel isoform and a previously reported ghrelin gene variant, ghrelin gene-derived transcript. We also demonstrated the tissue expression of the functional GHS-R in the mouse. Immunohistochemistry, employing antibodies raised against the mature human n-octanoylated ghrelin peptide and the putative C-terminal peptide encoded by the exon 4-deleted proghrelin variant, was used to demonstrate protein expression of ghrelin and the variant in multiple mouse tissues including stomach, kidney, and reproductive tissues. The coexpression of ghrelin and its receptor in a wide range of murine tissues suggests varied autocrine/paracrine roles for these peptides. Exon 4-deleted proghrelin, a novel mouse proghrelin isoform with a unique C-terminal peptide sequence, is also widely expressed in the mouse and thus may possess biological activity in these tissues.
This article has been cited by other articles:
 |
|
 |
|
  R. D Kineman, M. D Gahete, and R. M Luque Identification of a mouse ghrelin gene transcript that contains intron 2 and is regulated in the pituitary and hypothalamus in response to metabolic stress J. Mol. Endocrinol., May 1, 2007; 38(5): 511 - 521. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. H. Park, Y. J. Oh, G. Y. Kim, S. E. Kim, K.-H. Paik, S. J. Han, A. H. Kim, S. H. Chu, E. K. Kwon, S. W. Kim, et al. Obestatin Is Not Elevated or Correlated with Insulin in Children with Prader-Willi Syndrome J. Clin. Endocrinol. Metab., January 1, 2007; 92(1): 229 - 234. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. P. Shearman, S.-P. Wang, S. Helmling, D. S. Stribling, P. Mazur, L. Ge, L. Wang, S. Klussmann, D. E. Macintyre, A. D. Howard, et al. Ghrelin Neutralization by a Ribonucleic Acid-SPM Ameliorates Obesity in Diet-Induced Obese Mice Endocrinology, March 1, 2006; 147(3): 1517 - 1526. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P L Jeffery, R E Murray, A H Yeh, J F McNamara, R P Duncan, G D Francis, A C Herington, and L K Chopin Expression and function of the ghrelin axis, including a novel preproghrelin isoform, in human breast cancer tissues and cell lines Endocr. Relat. Cancer, December 1, 2005; 12(4): 839 - 850. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. H. Yeh, P. L. Jeffery, R. P. Duncan, A. C. Herington, and L. K. Chopin Ghrelin and a Novel Preproghrelin Isoform Are Highly Expressed in Prostate Cancer and Ghrelin Activates Mitogen-Activated Protein Kinase in Prostate Cancer Clin. Cancer Res., December 1, 2005; 11(23): 8295 - 8303. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |
